JP2008546826A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546826A5 JP2008546826A5 JP2008518824A JP2008518824A JP2008546826A5 JP 2008546826 A5 JP2008546826 A5 JP 2008546826A5 JP 2008518824 A JP2008518824 A JP 2008518824A JP 2008518824 A JP2008518824 A JP 2008518824A JP 2008546826 A5 JP2008546826 A5 JP 2008546826A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- diaza
- spiro
- undecane
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 13
- 208000035475 disorder Diseases 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 208000002193 Pain Diseases 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000001475 halogen functional group Chemical group 0.000 claims 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 208000011580 syndromic disease Diseases 0.000 claims 4
- 206010012289 Dementia Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 208000019906 panic disease Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- -1 trifluoromethoxy, cyano, hydroxy, amino Chemical group 0.000 claims 3
- UURPZDUBVYSYRO-UHFFFAOYSA-N 3-pyridin-4-yl-3,9-diazaspiro[5.5]undecane Chemical compound C1CNCCC21CCN(C=1C=CN=CC=1)CC2 UURPZDUBVYSYRO-UHFFFAOYSA-N 0.000 claims 2
- GMQPELBCDCDDHW-UHFFFAOYSA-N 4-(3,9-diazaspiro[5.5]undecan-3-yl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1N1CCC2(CCNCC2)CC1 GMQPELBCDCDDHW-UHFFFAOYSA-N 0.000 claims 2
- 208000007848 Alcoholism Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010013654 Drug abuse Diseases 0.000 claims 2
- 208000030814 Eating disease Diseases 0.000 claims 2
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 2
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 2
- 206010034912 Phobia Diseases 0.000 claims 2
- 206010041250 Social phobia Diseases 0.000 claims 2
- 206010043269 Tension headache Diseases 0.000 claims 2
- 208000008548 Tension-Type Headache Diseases 0.000 claims 2
- 206010043903 Tobacco abuse Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 235000014632 disordered eating Nutrition 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 201000001881 impotence Diseases 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 206010027175 memory impairment Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000036651 mood Effects 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- DPDHRMKSTVQDLK-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-3,9-diazaspiro[5.5]undecane Chemical compound ClC1=CC=CC(N2CCC3(CCNCC3)CC2)=C1Cl DPDHRMKSTVQDLK-UHFFFAOYSA-N 0.000 claims 1
- DTJZUJRFRZODRN-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-3,9-diazaspiro[5.5]undecane Chemical compound C1=C(Cl)C(Cl)=CC=C1N1CCC2(CCNCC2)CC1 DTJZUJRFRZODRN-UHFFFAOYSA-N 0.000 claims 1
- RPKIOJIUIYWHRX-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-9-methyl-3,9-diazaspiro[5.5]undecane Chemical compound C1CN(C)CCC21CCN(C=1C=C(Cl)C(Cl)=CC=1)CC2 RPKIOJIUIYWHRX-UHFFFAOYSA-N 0.000 claims 1
- HDOQASGLCCWZHE-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-3,9-diazaspiro[5.5]undecane Chemical compound C1=C(Cl)C(F)=CC=C1N1CCC2(CCNCC2)CC1 HDOQASGLCCWZHE-UHFFFAOYSA-N 0.000 claims 1
- LWOSASCBPIUUSY-UHFFFAOYSA-N 3-(4-chlorophenyl)-3,9-diazaspiro[5.5]undecane Chemical compound C1=CC(Cl)=CC=C1N1CCC2(CCNCC2)CC1 LWOSASCBPIUUSY-UHFFFAOYSA-N 0.000 claims 1
- LEAIRUOJCWLHDU-UHFFFAOYSA-N 3-(5-bromopyridin-2-yl)-3,9-diazaspiro[5.5]undecane Chemical compound N1=CC(Br)=CC=C1N1CCC2(CCNCC2)CC1 LEAIRUOJCWLHDU-UHFFFAOYSA-N 0.000 claims 1
- ZQGABIFHESFIMR-UHFFFAOYSA-N 3-(5-chloropyridin-2-yl)-3,9-diazaspiro[5.5]undecane Chemical compound N1=CC(Cl)=CC=C1N1CCC2(CCNCC2)CC1 ZQGABIFHESFIMR-UHFFFAOYSA-N 0.000 claims 1
- BFRWWHZDBGJRFY-UHFFFAOYSA-N 3-(6-bromopyridin-2-yl)-3,9-diazaspiro[5.5]undecane Chemical compound BrC1=CC=CC(N2CCC3(CCNCC3)CC2)=N1 BFRWWHZDBGJRFY-UHFFFAOYSA-N 0.000 claims 1
- WQQIMNSWIYAMGH-UHFFFAOYSA-N 3-(6-chloropyridin-2-yl)-3,9-diazaspiro[5.5]undecane Chemical compound ClC1=CC=CC(N2CCC3(CCNCC3)CC2)=N1 WQQIMNSWIYAMGH-UHFFFAOYSA-N 0.000 claims 1
- GJLKAESIOQHGAD-UHFFFAOYSA-N 3-(6-chloropyridin-2-yl)-9-methyl-3,9-diazaspiro[5.5]undecane Chemical compound C1CN(C)CCC21CCN(C=1N=C(Cl)C=CC=1)CC2 GJLKAESIOQHGAD-UHFFFAOYSA-N 0.000 claims 1
- LPRLCYNYVOSEQG-UHFFFAOYSA-N 3-(6-methoxynaphthalen-2-yl)-3,9-diazaspiro[5.5]undecane Chemical compound C1=CC2=CC(OC)=CC=C2C=C1N(CC1)CCC21CCNCC2 LPRLCYNYVOSEQG-UHFFFAOYSA-N 0.000 claims 1
- VYZMIEPDFFXWHZ-UHFFFAOYSA-N 3-(6-methoxynaphthalen-2-yl)-9-methyl-3,9-diazaspiro[5.5]undecane Chemical compound C1=CC2=CC(OC)=CC=C2C=C1N(CC1)CCC21CCN(C)CC2 VYZMIEPDFFXWHZ-UHFFFAOYSA-N 0.000 claims 1
- GZUGXRNUNFDUSK-UHFFFAOYSA-N 3-naphthalen-2-yl-3,9-diazaspiro[5.5]undecane Chemical compound C1CNCCC21CCN(C=1C=C3C=CC=CC3=CC=1)CC2 GZUGXRNUNFDUSK-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 208000000103 Anorexia Nervosa Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000036640 Asperger disease Diseases 0.000 claims 1
- 201000006062 Asperger syndrome Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000027448 Attention Deficit and Disruptive Behavior disease Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000022497 Cocaine-Related disease Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000026097 Factitious disease Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 208000020358 Learning disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000026139 Memory disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 208000008705 Nocturnal Myoclonus Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 206010033664 Panic attack Diseases 0.000 claims 1
- 206010052794 Panic disorder with agoraphobia Diseases 0.000 claims 1
- 206010033668 Panic disorder without agoraphobia Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 208000012202 Pervasive developmental disease Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 206010070606 Post stroke depression Diseases 0.000 claims 1
- 208000008348 Post-Concussion Syndrome Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- 206010052276 Pseudodementia Diseases 0.000 claims 1
- 208000005793 Restless legs syndrome Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000011962 Substance-induced mood disease Diseases 0.000 claims 1
- 231100000395 Substance-induced mood disorder Toxicity 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000031674 Traumatic Acute Stress disease Diseases 0.000 claims 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 208000026345 acute stress disease Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 208000025748 atypical depressive disease Diseases 0.000 claims 1
- 208000029560 autism spectrum disease Diseases 0.000 claims 1
- 208000022266 body dysmorphic disease Diseases 0.000 claims 1
- 230000006931 brain damage Effects 0.000 claims 1
- 231100000874 brain damage Toxicity 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 201000001272 cocaine abuse Diseases 0.000 claims 1
- 210000004246 corpus luteum Anatomy 0.000 claims 1
- 125000004858 cycloalkoxyalkyl group Chemical group 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 210000001097 facial muscle Anatomy 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 201000003723 learning disability Diseases 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000006984 memory degeneration Effects 0.000 claims 1
- 208000023060 memory loss Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 208000013465 muscle pain Diseases 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 201000003631 narcolepsy Diseases 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 230000003961 neuronal insult Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 239000002858 neurotransmitter agent Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000024196 oppositional defiant disease Diseases 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000023515 periodic limb movement disease Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 208000019899 phobic disease Diseases 0.000 claims 1
- 208000024335 physical disease Diseases 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 230000002028 premature Effects 0.000 claims 1
- 206010036596 premature ejaculation Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000002889 sympathetic effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000016686 tic disease Diseases 0.000 claims 1
- 231100000886 tinnitus Toxicity 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 208000002271 trichotillomania Diseases 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 206010046494 urge incontinence Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500960 | 2005-06-28 | ||
| US69467805P | 2005-06-29 | 2005-06-29 | |
| PCT/EP2006/063631 WO2007000463A1 (en) | 2005-06-28 | 2006-06-28 | Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008546826A JP2008546826A (ja) | 2008-12-25 |
| JP2008546826A5 true JP2008546826A5 (enExample) | 2009-08-13 |
Family
ID=36954352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518824A Abandoned JP2008546826A (ja) | 2005-06-28 | 2006-06-28 | 新規な３，９−ジアザ−スピロ［５．５］ウンデカン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのこれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7943630B2 (enExample) |
| EP (1) | EP1917264B1 (enExample) |
| JP (1) | JP2008546826A (enExample) |
| WO (1) | WO2007000463A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
| CN111533739B (zh) * | 2020-05-08 | 2023-05-05 | 上海皓鸿生物医药科技有限公司 | 3-烷基-3,9-二氮杂螺[5,5]十一烷的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4041174A (en) * | 1974-08-16 | 1977-08-09 | Rom-Amer Pharmaceuticals, Ltd. | Method of treating depression |
| US5451578A (en) * | 1994-08-12 | 1995-09-19 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| RU2162469C2 (ru) | 1995-11-02 | 2001-01-27 | Ньюросерч А/С | Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов |
| ZA971525B (en) | 1996-02-22 | 1997-10-21 | Neurosearch As | Tropane derivatives, their preparation and use. |
-
2006
- 2006-06-28 JP JP2008518824A patent/JP2008546826A/ja not_active Abandoned
- 2006-06-28 US US11/922,931 patent/US7943630B2/en not_active Expired - Fee Related
- 2006-06-28 WO PCT/EP2006/063631 patent/WO2007000463A1/en not_active Ceased
- 2006-06-28 EP EP06763927A patent/EP1917264B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007106970A (ru) | Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов | |
| RU2018130727A (ru) | Органические соединения | |
| JP2009538866A5 (enExample) | ||
| JP2010513392A5 (enExample) | ||
| RU2007139541A (ru) | Производные хромана и хромена и их применение | |
| JP2010523651A5 (enExample) | ||
| EA200800430A1 (ru) | Замещённые тетрагидро-1н-пиридо[4,3,b] индолы как агонисты и антагонисты серотониновых рецепторов | |
| JP2009526816A5 (enExample) | ||
| NZ580802A (en) | Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
| JP2007520539A5 (enExample) | ||
| JP2009537599A5 (enExample) | ||
| RU2008129865A (ru) | Новые производные хромен-2-она и их применение в качестве ингибиторов обратного захвата нейромедиаторов моноаминов | |
| RU2010135035A (ru) | Новые триарильные производные, полезные в качестве модуляторов никотиновых ацетилхолиновых рецепторов | |
| JP2006517567A5 (enExample) | ||
| RU2008110911A (ru) | Новые диазабициклические арильные производные и их медицинское применение | |
| JP2008546826A5 (enExample) | ||
| JP2008502651A5 (enExample) | ||
| JP2006517568A5 (enExample) | ||
| JP2010513391A5 (enExample) | ||
| JP2009526023A5 (enExample) | ||
| JP2008524161A5 (enExample) | ||
| JP2008546828A5 (enExample) | ||
| JP2007523206A5 (enExample) | ||
| JPWO2020132474A5 (enExample) | ||
| JP2008546827A5 (enExample) |